It describes a group of chronic metabolic disorders characterized by persistent high blood sugar levels (hyperglycemia) caused by insulin resistance, inadequate secretion of insulin or excessive secretion of glucagon (Lipscombe and Hux, 2007; Blair, 2016). Here, INS is linked to Hyperglycemia.